These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22913237)

  • 1. [An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].
    Petejová N; Martínek A; Zahálková J; Duricová J; Plášek J; Valkovský I; Grundmann M; Kacířová I
    Vnitr Lek; 2012 Jun; 58(6):448-54. PubMed ID: 22913237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial dosing in critically ill patients requiring renal replacement therapy - maximize efficacy and minimize toxicity!].
    Radej J; Matejovic M
    Vnitr Lek; 2012 Jun; 58(6):427-9. PubMed ID: 22937557
    [No Abstract]   [Full Text] [Related]  

  • 3. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents-Pathophysiology and Biomarkers-A Review.
    Petejova N; Martinek A; Zadrazil J; Kanova M; Klementa V; Sigutova R; Kacirova I; Hrabovsky V; Svagera Z; Stejskal D
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies].
    Carcelero E; Soy D
    Enferm Infecc Microbiol Clin; 2012 May; 30(5):249-56. PubMed ID: 22130573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock.
    Vázquez M; Fagiolino P; Boronat A; Buroni M; Maldonado C
    Int J Clin Pharmacol Ther; 2008 Mar; 46(3):140-5. PubMed ID: 18397685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Li AM; Lipman J
    Blood Purif; 2010; 30(3):195-212. PubMed ID: 20924175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA; Covajes C; Taccone FS; Jacobs F; Vincent JL; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of acute kidney injury in septic shock patients: an observational cohort study.
    Plataki M; Kashani K; Cabello-Garza J; Maldonado F; Kashyap R; Kor DJ; Gajic O; Cartin-Ceba R
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1744-51. PubMed ID: 21734090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors determining a low dose of haemodialysis as measured by ionic dialysance in critical patients with acute kidney injury.
    Rosa-Diez G; Greloni G; Crucelegui M; Bedini-Roca M; Heredia-Martínez A; Coli ML; Giannasi S; San-Román E; Pizarro R; Belzitti C; Algranati S; Heguilen R
    Nefrologia; 2012 May; 32(3):359-66. PubMed ID: 22535160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P; Bergamasco S; Donadio C
    Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the time from sepsis to inception of continuous renal replacement therapy versus RIFLE criteria in patients with septic acute kidney injury.
    Chon GR; Chang JW; Huh JW; Lim CM; Koh Y; Park SK; Park JS; Hong SB
    Shock; 2012 Jul; 38(1):30-6. PubMed ID: 22706021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial dosing of vancomycin in critically ill patients.
    Kees MG; Vögeler S; Hilpert JW
    Int J Antimicrob Agents; 2011 Jul; 38(1):91-2. PubMed ID: 21546217
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
    Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis: update in the management.
    Venkataraman R; Kellum JA
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):6-13. PubMed ID: 23265591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney insufficiency in the critically ill.
    Bentley ML
    J Pharm Pract; 2011 Feb; 24(1):61-9. PubMed ID: 21507875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early achievement of physiologic resuscitation goals in septic patients admitted from the ward on the kidneys.
    Kiers HD; Griesdale DE; Litchfield A; Reynolds S; Gibney RT; Chittock D; Pickkers P; Sweet DD
    J Crit Care; 2010 Dec; 25(4):563-9. PubMed ID: 20646899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell therapy in the treatment of patients with acute and chronic renal failure.
    Humes HD; Weitzel WF; Fissell WH
    Blood Purif; 2004; 22(1):60-72. PubMed ID: 14732813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.